Articles

Sequence-specific 2'-O-methoxyethyl antisense oligonucleotides activate human platelets through glycoprotein VI, triggering formation of platelet-leukocyte aggregates

Vascular Biology Program, Department of Surgery, Boston Children’s Hospital, Boston, MA, USA; Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Vascular Biology Program, Department of Surgery, Boston Children’s Hospital, Boston, MA, USA; Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Vascular Biology Program, Department of Surgery, Boston Children’s Hospital, Boston, MA, USA; Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Nonclinical Development, Ionis Pharmaceuticals Inc., Carlsbad, CA
Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Departments of Pharmacology and Medicine, University of Toronto, Toronto, Canada; Division of Hematology and Transfusion Medicine, Lund University, Lund
Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Nonclinical Development, Ionis Pharmaceuticals Inc., Carlsbad, CA
Nonclinical Development, Ionis Pharmaceuticals Inc., Carlsbad, CA
Vascular Biology Program, Department of Surgery, Boston Children’s Hospital, Boston, MA, USA; Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Vol. 107 No. 2 (2022): February, 2022 https://doi.org/10.3324/haematol.2020.260059